Novartis, Takeda to enter next Medicare drug price negotiationsnews2026-02-27T19:43:29+00:00February 27th, 2026|Endpoints News|
US International Trade Commission to take a closer look at Chinese biotechnews2026-02-27T19:20:24+00:00February 27th, 2026|Endpoints News|
Merck cuts more than 150 jobs at new Gardasil vaccine plant in North Carolinanews2026-02-27T19:11:35+00:00February 27th, 2026|Endpoints News|
CHMP recommends Moderna’s flu-Covid shot and Novartis pill for hivesnews2026-02-27T18:16:15+00:00February 27th, 2026|Endpoints News|
Generate:Biomedicines raises $400M IPO, CEO talks about AI’s future in drug designnews2026-02-27T16:38:54+00:00February 27th, 2026|Endpoints News|
WuXi XDC makes an ADC linker deal with Earendil for up to $885Mnews2026-02-27T16:13:26+00:00February 27th, 2026|Endpoints News|
Ginkgo divests biosecurity arm; J&J’s early prostate cancer datanews2026-02-27T15:14:31+00:00February 27th, 2026|Endpoints News|
Padcev-Keytruda combo delivers more positive data in bladder cancernews2026-02-27T15:00:05+00:00February 27th, 2026|Endpoints News|
Novartis closes Avidity deal as rare heart disease spinout launchesnews2026-02-27T14:51:42+00:00February 27th, 2026|Endpoints News|
Investors are pumping money into AI tools for health insurersnews2026-02-27T14:00:27+00:00February 27th, 2026|Endpoints News|
